| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.31 | 0.0009 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.098 | 0.001 |